Search research articles
Contact Us
Filters
Showing results (491-500 of 524) with videos related to
Page
of 53
Sort By:
JAMA Surgery
|
January 5, 2018
Effect of Standardized Handoff Curriculum on Improved Clinician Preparedness in the Intensive Care Unit: A Stepped-Wedge Cluster Randomized Clinical Trial
Brodie Parent, Lacey N LaGrone, Mohamed T Albirair, et al.
Circulation. Genomic and Precision Medicine
|
October 1, 2021
Rare, Damaging DNA Variants in <i>CORIN</i> and Risk of Coronary Artery Disease: Insights From Functional Genomics and Large-Scale Sequencing Analyses
Minxian Wang, Vivian S Lee-Kim, Deepak S Atri, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 4, 2009
Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease
Antonio Di Sabatino, Laura Rovedatti, Rejbinder Kaur, et al.
Frontiers in Cardiovascular Medicine
|
May 25, 2026
Real-world experience with sodium-glucose cotransporter 2 inhibitors in adults with Fontan circulatory failure
Ralph M L Neijenhuis, Ari M Cedars, Ali Zaidi, et al.
Gut
|
December 4, 2019
Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells
Nick Powell, Eirini Pantazi, Polychronis Pavlidis, et al.
Gastroenterology
|
April 29, 2015
Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation
Nick Powell, Jonathan W Lo, Paolo Biancheri, et al.
The New England Journal of Medicine
|
October 21, 2011
Inflammatory skin and bowel disease linked to ADAM17 deletion
Diana C Blaydon, Paolo Biancheri, Wei-Li Di, et al.
ESMO Open
|
June 25, 2026
Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial
A Lamarca, D H Palmer, H S Wasan, et al.
Gut
|
February 26, 2015
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease
James B Canavan, Cristiano Scottà, Anna Vossenkämper, et al.
Nature Medicine
|
May 24, 2011
Lrp5 functions in bone to regulate bone mass
Yajun Cui, Paul J Niziolek, Bryan T MacDonald, et al.
Page
of 53
Search research articles
Search
Showing results (491-500 of 524) with videos related to
Sort By:
Page
of 53
JAMA Surgery
|
January 5, 2018
Effect of Standardized Handoff Curriculum on Improved Clinician Preparedness in the Intensive Care Unit: A Stepped-Wedge Cluster Randomized Clinical Trial
Brodie Parent, Lacey N LaGrone, Mohamed T Albirair, et al.
Circulation. Genomic and Precision Medicine
|
October 1, 2021
Rare, Damaging DNA Variants in <i>CORIN</i> and Risk of Coronary Artery Disease: Insights From Functional Genomics and Large-Scale Sequencing Analyses
Minxian Wang, Vivian S Lee-Kim, Deepak S Atri, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 4, 2009
Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease
Antonio Di Sabatino, Laura Rovedatti, Rejbinder Kaur, et al.
Frontiers in Cardiovascular Medicine
|
May 25, 2026
Real-world experience with sodium-glucose cotransporter 2 inhibitors in adults with Fontan circulatory failure
Ralph M L Neijenhuis, Ari M Cedars, Ali Zaidi, et al.
Gut
|
December 4, 2019
Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells
Nick Powell, Eirini Pantazi, Polychronis Pavlidis, et al.
Gastroenterology
|
April 29, 2015
Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation
Nick Powell, Jonathan W Lo, Paolo Biancheri, et al.
The New England Journal of Medicine
|
October 21, 2011
Inflammatory skin and bowel disease linked to ADAM17 deletion
Diana C Blaydon, Paolo Biancheri, Wei-Li Di, et al.
ESMO Open
|
June 25, 2026
Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial
A Lamarca, D H Palmer, H S Wasan, et al.
Gut
|
February 26, 2015
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease
James B Canavan, Cristiano Scottà, Anna Vossenkämper, et al.
Nature Medicine
|
May 24, 2011
Lrp5 functions in bone to regulate bone mass
Yajun Cui, Paul J Niziolek, Bryan T MacDonald, et al.
Page
of 53